Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma
SCG Cell Therapy Pte. Ltd.
SCG Cell Therapy Pte. Ltd.
HRYZ Biotech Co.
Dana-Farber Cancer Institute
Genocea Biosciences, Inc.
Corregene Biotechnology Co., Ltd
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center